IPAS161
Extinção de registro pela expiração do prazo de vigência
RPI 2517
04/02/2019
Back to search
Official data from INPI
ANDREWS LIVER SALT
This trademark appears in the official INPI history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
Registro de marca extintoType: WordOffice: Brazil
Quick snapshot
ANDREWS LIVER SALT
ST13
BR500000002317656Class
5
Filing
002317656
Registration
002317656
Progress at the INPI
- Filing07/08/48
- Publication
- Examination
- Allowance
- Grant07/08/48
- Terminated04/02/19
The registration was granted on 07/08/1948 and later terminated. The mark is no longer protected.
Check whether this name is availableLatest action published by the INPI: 04/02/2019. We update with every new RPI gazette, published weekly.
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
INPI status
Registro de marca extinto
Case type
Application and registration
Recorded events
7
Latest update
04/02/2019
Trademark type
Word
Nice classes
5
Filing date
07/08/1948
Registration date
07/08/1948
Expiration date
07/08/2018
Complete case details
Structured fields from the responsible authority and the official record.
Nature
De Produto
Responsible office
Brazil
Owner type
NÃO RESIDENTE
Owner location
GB
Holders and representatives
Holders
GlaxoSmithKline Consumer Healthcare (UK) IP Limited
Representatives
Dannemann SiemsenVer perfil do escritório
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Produto farmacêutico usado nas doenças do figado
Publications
History of INPI decisions and trademark events.
7 publications found
IPAS270
Deferimento da petição
Protocolo: 850170079666 (12/04/2017) Petição (tipo): Anotação de transferência de titularidade decorrente de cessão (349.1) Procurador: Dannemann, Siemsen, Bigler & Ipanema Moreira Cessionário: GlaxoSmithKline Consumer Healthcare (UK) IP Limited
RPI 2468
04/24/2018
560
ANOTADA A ALTERAÇÃO DE NOME e/ou DE SEDE/ENDEREÇO.
NOME ALTERADO
RPI 2158
05/15/2012
990
CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.
PRORROGADO CONFORME RESOLUÇÃO 123 DE 06/01/2006, PUBLICADA NA RPI 1829, DE 24/01/2006.
RPI 2021
09/29/2009
565
ANOTADA A TRANSFERENCIA.
CED. THE SYDNEI ROSS CO. (US)
RPI 1472
03/23/1999
990
CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.
RPI 1451
10/27/1998
990
CONCEDIDA A PRORROGACAO DO REGISTRO. O Certificado de prorrogacao de Registro estara a disposicao do Titular na Recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.
RPI 938
10/11/1988
GlaxoSmithKline Consumer Healthcare (UK) IP Limited also protects technology and design at the INPI
12 patent applications and 15 industrial designs under the same owner.
Patents
Related trademarks
Other trademarks by GlaxoSmithKline Consumer Healthcare (UK) IP Limited
Continuous trademark protection
Get notified about every new filing that threatens ANDREWS LIVER SALT or your mark.
Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.